Abstract: A self-service terminal service contingency method and a site server are provided. The method includes: acquiring self-service services corresponding to a self-service terminal under a self-service site; detecting whether a service is lacked among the self-service services, and if yes, acquiring resources and/or components required by the lacked service, of the self-service terminal; detecting whether the self-service site has the resources and/or components required by the lacked service, of the self-service terminal, and if yes, integrating the resources and/or the components under the self-service network according to a preset combination rule; and driving the integrated resources and/or the components to cooperate with each other according to a preset optimization rule, so as to enable the self-service site to provide a self-service service corresponding to the lacked service.

Abstract: A platform-level container configured to hold natively-supported ink stroke data structures is maintained. The platform-level container is accessible to a plurality of different applications. An ink stroke visual corresponding to each ink stroke data structure held by the platform-level container is rendered via a display. An ink stroke change event corresponding to an ink stroke data structure held by the platform-level container is recognized. The ink stroke data structure is changed to an updated ink stroke data structure in accordance with the ink stroke change event. An ink stroke visual corresponding to the updated ink stroke data structure is rendered via the display without re-rendering ink stroke visuals corresponding to unchanged ink stroke data structures.

Abstract: A facility for handling input relating to electronic ink is described. In a first thread, the facility produces ink in response to at least a portion of the input. In a second thread distinct from the first thread, the facility manipulates at least a portion of the ink produced in the first thread.

Abstract: The present invention concerns therapeutic agents that modulate the activity of TALL-1. In accordance with the present invention, modulators of TALL-1 may comprise an amino acid sequence Dz2Lz4 wherein z2 is an amino acid residue and z4 is threonyl or isoleucyl. Exemplary molecules comprise a sequence of the formulae (SEQ.?ID.?NO:?100) a1a2a3CDa6La8a9a10Ca12a13a14, (SEQ.?ID.?NO:?104) b1b2b3Cb6Db8Lb10b11b12b13b14Cb16b17b18 (SEQ.?ID.?NO:?105) c1c2c3Cc5Dc7Lc9c10c11c12c13c14Cc16c17c18 (SEQ.?ID.?NO:?106) d1d2d3Cd5d6d7WDd10Ld13d14d15Ld16d17d18 (SEQ.?ID.?NO:?107) e1e2e3Ce5e6e7De9Le11Ke13ce15e16e17e18 (SEQ.?ID?NO:?109) f1f2f3Kf5Df7Lf9f10Qf12f13f14 wherein the substituents are as defined in the specification. The invention further comprises compositions of matter of the formula (X1)a—V1—(X2)b wherein V1 is a vehicle that is covalently attached to one or more of the above TALL-1 modulating compositions of matter.

Abstract: Systems and methods are provided for improving the latency for display of ink during user creation of ink content with a stylus, mouse, finger (or other touch input), or other drawing device for tracing a desired location for ink content in a display area. In order to reduce or minimize the time for display of ink content created by a user using a stylus/mouse/touch input/other device, a separate ink rendering process thread can be used that operates within the operating system and in parallel to other application threads. When it is desired to create ink content within an application, user interactions corresponding to creation of ink content can be handled by the separate ink rendering process thread. This can avoid potential delays in displaying ink content due to an application handling other events in a process flow.

Abstract: Systems and methods are provided for improving the latency for display of ink during user creation of ink content with an object, such as a stylus, mouse, finger (or other touch input), or other drawing device. In order to reduce or minimize the time for display of ink content created by a user, aspects of the technology described herein generate predictive wet ink that can be displayed with actual wet ink. The predictive wet ink is calculated by extending an active ink segment a predictive distance. The predictive distance is intended to be a distance between a termination ink point for an active wet ink segment and a tip of the writing object. In one aspect, the predictive distance is calculated by determining the current latency period on a touch device and the velocity of the writing object.

Abstract: Disclosed is a fuel injection control system for a single-cylinder diesel engine, comprising: a set of operating condition sensors including an accelerator pedal position sensor and a cooling water temperature sensor, an input signal interface capable of receiving an input signal from the operating condition sensors, a control unit connected to the input signal interface, and a rotational speed sensor provided at a camshaft or starting shaft of the single-cylinder diesel engine. The rational speed sensor is connected to the control unit via a rotational speed correction circuit. The control system can easily and quickly determine the rotational speed and operating stroke of the single-cylinder diesel engine, so as to quickly determine the fuel injection quantity and injection timing of the single-cylinder diesel engine in real time.

Abstract: Disclosed is a process for preparing a pharmacologically active compound, in which at least one internal conjugation site of an Fc domain sequence is selected that is amenable to conjugation of an additional functional moiety by a defined conjugation chemistry through the side chain of an amino acid residue at the conjugation site. An appropriate amino acid residue for conjugation may be present in a native Fc domain at the conjugation site or may be added by insertion (i.e., between amino acids in the native Fc domain) or by replacement (i.e., removing amino acids and substituting different amino acids). In the latter case, the number of amino acids added need not correspond to the number of amino acids removed from the previously existing Fc domain. This technology may be used to produce useful compositions of matter and pharmaceutical compositions containing them.

Abstract: The present invention concerns therapeutic agents that modulate the activity of TALL-1. In accordance with the present invention, modulators of TALL-1 may comprise an amino acid sequence Dz2Lz4 wherein z2 is an amino acid residue and z4 is threonyl or isoleucyl. Exemplary molecules comprise a sequence of the formulae (SEQ. ID. NO: 100) a1a2a3CDa6La8a9a10Ca12a13a14, (SEQ. ID. NO: 104) b1b2b3Cb5b6Db8Lb10b11b12b13b14Cb16b17b18 (SEQ. ID. NO: 105) c1c2c3Cc5Dc7Lc9c10c11c12c13c14Cc16c17c18 (SEQ. ID. NO: 106) d1d2d3Cd5d6d7WDd10Ld13d14d15Ld16d17d18 (SEQ. ID. NO: 107) e1e2e3Ce5e6e7De9Le11Ke13Ce15e16e17e18 (SEQ. ID NO: 109) f1f2f3Kf5Df7Lf9f10Qf12f13f14 wherein the substituents are as defined in the specification.

Abstract: Disclosed is a process for preparing a pharmacologically active compound, in which at least one internal conjugation site of an Fc domain sequence is selected that is amenable to conjugation of an additional functional moiety by a defined conjugation chemistry through the side chain of an amino acid residue at the conjugation site. An appropriate amino acid residue for conjugation may be present in a native Fc domain at the conjugation site or may be added by insertion (i.e., between amino acids in the native Fc domain) or by replacement (i.e., removing amino acids and substituting different amino acids). In the latter case, the number of amino acids added need not correspond to the number of amino acids removed from the previously existing Fc domain. This technology may be used to produce useful compositions of matter and pharmaceutical compositions containing them.

Abstract: A switching power supply comprising a switching circuit and a controller. The controller comprises a preprocessing circuit, a first multiplier, a first comparing circuit and a logic circuit. The controller comprises a preprocessing circuit, a first multiplier, a first comparing circuit and a logic circuit. The preprocessing circuit generates a first multiplication input signal based on the input voltage and output voltage of the switching circuit. The first multiplier multiplies the first multiplication input signal by a second multiplication input signal and generates a first product signal. The first comparing circuit compares a current sensing signal representative of the input current with the first product signal and generates a first comparison signal. The logic circuit turns off a main switch in the switching circuit when the current sensing signal is larger than the first product signal.

Abstract: High performance touch drag and drop are described. In embodiments, a multi-threaded architecture is implemented to include at least a manipulation thread and an independent hit test thread. The manipulation thread is configured to receive one or more messages associated with an input and send data associated with the messages to the independent hit test thread. The independent hit test thread is configured to perform an independent hit test to determine whether the input hit an element that is eligible for a particular action, and identify an interaction model associated with the input. The independent hit test thread also sends an indication of the interaction model to the manipulation thread to enable the manipulation thread to detect whether the particular action is triggered.

Abstract: System and method for LED light source. According to an embodiment, the present invention provides a an LED light system for emitting substantially white light. The system includes a first dichroic element, the first dichroic element comprises a first dichroic surface having a first coating, the first coating being adapted to reflect over 95% of a first color and transmit over 95% of a second color, the first dichroic surface having a first side and a second side. The system also includes a second dichroic element, the second dichroic element comprises a second dichroic surface having a second coating, the second coating being adapted to reflect over 95% of a third color and transmit 95% of a fourth color, the second dichroic surface having a third side and a fourth side.

Abstract: The present invention provides a means for increasing the serum half-life of a selected biologically active agent by utilizing transthyretin (TTR) as a fusion partner with a biologically active agent. Specifically, the present invention provides substantially homogenous preparations of TTR (or a TTR variant)-biologically active agent fusions and PEG-TTR (PEG-TTR variant)-biologically active agent fusions. As compared to the biologically active agent alone, the TTR-biologically active agent fusion and/or PEG-TTR-biologically active agent fusion has substantially increased serum half-life.

Abstract: The present invention concerns therapeutic agents that modulate the activity of TALL-1. In accordance with the present invention, modulators of TALL-1 may comprise an amino acid sequence Dz2Lz4 wherein z2 is an amino acid residue and z4 is threonyl or isoleucyl. Exemplary molecules comprise a sequence of the formulae (SEQ. ID. NO: 100) a1a2a3CDa6La8a9a10Ca12a13a14, (SEQ. ID. NO: 104) b1b2b3Cb5b6Db8Lb10b11b12b13b14Cb16b17b18 (SEQ. ID. NO: 105) c1c2c3Cc5Dc7Lc9c10c11c12c13c14Cc16c17c18 (SEQ. ID. NO: 106) d1d2d3Cd5d6d7WDd10Ld13d14d15Ld16d17d18 (SEQ. ID. NO: 107) e1e2e3Ce5e6e7De9Le11Ke13Ce15e16e17e18 (SEQ. ID NO: 109) f1f2f3Kf5Df7Lf9f10Qf12f13f14 wherein the substituents are as defined in the specification.

Abstract: The present invention provides a means for increasing the serum half-life of a selected biologically active agent by utilizing transthyretin (TTR) as a fusion partner with a biologically active agent. Specifically, the present invention provides substantially homogenous preparations of TTR (or a TTR variant)-biologically active agent fusions and PEG-TTR (PEG-TTR variant)-biologically active agent fusions. As compared to the biologically active agent alone, the TTR-biologically active agent fusion and/or PEG-TTR-biologically active agent fusion has substantially increased serum half-life.

Abstract: A process for preparing an enantiomerically enriched cycloalkene-substituted alanine compound having the structure: by asymmetrically hydrogenating a dehydro amino acid compound having the structure: in a suitable reaction media in the presence of a catalyst having a transition metal moiety complexed to a chiral phosphine ligand to prepare enantiomerically enriched cycloalkene substituted alanine compounds having the structure of Formula (IA) or (IB), which are key intermediates for the ACE inhibitors ramipril and perindolpril:

Abstract: The present invention concerns therapeutic agents that modulate the activity of TALL-1. In accordance with the present invention, modulators of TALL-1 may comprise an amino acid sequence Dz2Lz4 wherein z2 is an amino acid residue and z4 is threonyl or isoleucyl. Exemplary molecules comprise a sequence of the formulae (SEQ?ID?NO:?100) a1a2a3CDa6La8a9a10Ca12a13a14, (SEQ?ID?NO:?104) b1b2b3Cb5b6Db8Lb10b11b12b13b14Cb16b17b18 (SEQ?ID?NO:?105) c1c2c3Cc5DC7Lc9c10c11c12c13c14Cc16c17c18 (SEQ?ID?NO:?106) d1d2d3Cd5d6d7WDd10Ld13d14d15Ld16d17d18 (SEQ?ID?NO:?107) e1e2e3Ce5e6e7De9Le11Ke13Ce15e16e17e18 (SEQ?ID?NO:?109) f1f2f3Kf5Df7Lf9f10Qf12f13f14 wherein the substituents are as defined in the specification.

Abstract: Techniques involving dynamic colorization of graphical user interfaces. One representative technique includes enabling a user to specify colors in which user interface elements will be colored in an application. An application colorization service is initiated in response to the user specification of the colors, which is used at least to obtain the colors specified by the user, and to create bitmap images of the application's user interface elements using the user-specified colors. A bitmap image output location is made accessible to the application to enable the application to retrieve the created bitmap images, and present the application using the application user interface elements having the user-specified colors.

Abstract: A switching power supply comprising a switching circuit and a controller. The controller comprises a preprocessing circuit, a first multiplier, a first comparing circuit and a logic circuit. The controller comprises a preprocessing circuit, a first multiplier, a first comparing circuit and a logic circuit. The preprocessing circuit generates a first multiplication input signal based on the input voltage and output voltage of the switching circuit. The first multiplier multiplies the first multiplication input signal by a second multiplication input signal and generates a first product signal. The first comparing circuit compares a current sensing signal representative of the input current with the first product signal and generates a first comparison signal. The logic circuit turns off a main switch in the switching circuit when the current sensing signal is larger than the first product signal.